Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Active
18 to 75
Other
UMCN-AKF 07.02
EudraCTnr 2007-003347-73, NCT00588835
2.
Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
Other
2006-0961
NCT00542542
3.
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
Pharmaceutical / Industry
NKV110721
NCT00601172
Last Modified:
11/10/2008
 
First Published:
1/25/2007
4.
Phase II Randomized Study of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients With Newly Diagnosed Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
8 to 18
NCI
HLMCC-0503
HLMCC 0503, NCT00429702
First Published:
11/19/2008
5.
Phase II Study of Ondansetron Hydrochloride for the Prevention of Dimethyl Sulfoxide-Related Nausea and Vomiting in Patients Receiving Cryopreserved Autologous Peripheral Blood Stem Cells
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
21 and over
NCI
FHCRC-2247.00
FHCRC-2247.00, IR-6765, NCT00795769
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute